Synapse - Mark Robson

Results (676)

Ductal lavage in patients undergoing mastectomy for mammary carcinoma: A correlative study

Journal Article

Brogi, E.; Robson, M.; Panageas, K. S.; Casadio, C.; Ljung, B. M.; Montgomery, L.
Cancer (2003)

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors

Journal Article

Antonescu, C. R.; Sommer, G.; Sarran, L.; Tschernyavsky, S. J.; Riedel, E.; Woodruff, J. M.; Robson, M.; Maki, R.; Brennan, M. F.; Ladanyi, M.; more...
Clinical Cancer Research (2003)

Fulltext@MSK | Save

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Journal Article

Robson, M. E.; Chappuis, P. O.; Satagopan, J.; Wong, N.; Boyd, J.; Goffin, J. R.; Hudis, C.; Roberge, D.; Norton, L.; Begin, L. R.; more...
Breast Cancer Research (2003)

Fulltext@MSK | Save

Incidence of non-founder BRCA1 and BRCA2 mutations in high-risk Ashkenazi breast and ovarian cancer families

Meeting Abstract

Kauff, N. D.; Perez-Segura, P.; Robson, M. E.; Scheuer, L.; Siegel, B.; Schluger, A.; Frank, T. S.; Nafa, K.; Parmigiani, G.; Offit, K.
Genetics in Medicine (2002)

Fulltext@MSK | Save

Effects of exemestane and raloxifene on breast density by mammography and MRI in postmenopausal women: Preliminary data from a pilot chemoprevention trial

Meeting Abstract

Dickler, M.; Morris, E.; Robson, M.; Choi, J.; Hummer, A.; Panageas, K.; Ballon, D.; Borgen, P.; Norton, L.; Hudis, C.
Cancer Epidemiology Biomarkers and Prevention (2002)

Fulltext@MSK | Save

Impact of tamoxifen on the risk of metachronous contralateral breast cancer in women with germline mutations of BRCA1 or BRCA2

Meeting Abstract

Robson, M. E.; Satagopan, J.; Hudis, C. A.; Boyd, J.; Offit, K.
Breast Cancer Research and Treatment (2002)

Fulltext@MSK | Save

[Commentary on] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial